Compugen (CGEN) Tops Q2 EPS by 1c

Compugen (NASDAQ: CGEN) reported Q2 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• B.Riley Assumes Anika Therapeutics (ANIK) at Buy
• UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'